I. Introduction
The selected drug Cyproheptadine hydrochloride (CPH) is a sedating antihistamine drug and is chemically known as 4-(5Hdibenzo [a,d]-cyclohepten-5-ylidene)-1-methylpiperidine hydrochloride [1] having molecular formula C 21 H 21 N.HCl and structural formula is as follows: Cyproheptadine hydrochloride (CPH) is an antihistaminic and antiserotonergic drug having a sedating action with serotonin-antagonist, antimuscarinic and calcium-channel blocking action in pancreatic islet cells and smooth muscle [2] . Engelhrdt et al., [3] was the first to synthesised this drug Cyproheptadine hydrochloride (CPH).This CPH is mainly used for treating symptoms of allergic reactions caused by seasonal allergies, food, blood or plasma. It is also used in allergy symptoms like runny nose, watery eyes, sneezing, hives, itching eyes/nose. CPH is also used as clinical and veterinary medicine.
The drug Cyproheptadine (CPH) has an atropine like action and therefore it should not be used in new born or premature infants, nursing mothers and also if patient have been affected by narrow-angle glaucoma, a peptic ulcer, an enlarged prostate or bladder , stomach or bowel blockage. Non-aqueous titration by using perchloric acid as titrant has been described by United States Pharmacoepia [4] where crystal violet is used as indicator for the detection of end point. Whereas Indian Pharmacopeia [5] mentioned use of UV spectrophotometer for the assay determination of its tablet in 0.1 M HCl at 286 nm.
The oxidising reagent used here for the determination of Cyproheptadine hydrochloride (CPH) is Pyridinium fluoro chromate (PFC) which is chromoium (VI) based oxidising reagent. Many researchers in field of chemistry have been extensively used chromium based compound as an oxidizing agent for both preparative [6] . Extensive work has led to the development of a good number of these oxidants such as the Collins reagent [7] , chromium trioxide-3,5-dimethylpyrazole complex [8] , pyridinium chlorochromate (PCC) [9] , pyridinium dichromate[10] 2,2'-bipyridinium chlorochromate [11] , pyridinium fluorochromate(PFC) [12, 13] , quinolinium fluorochromate [14] , quinolinium chlorochromate [15] , 3,5-dimethyl pyrazolium fluorochromate [16] , 2,6-dicarboxypyridinium chlorochromate [17, 18] , N-methylpiperidinium chlorochromate [19] , tetramethylammonium fluorochromate [20] and benzyltrimethylammonium fluorochromate [21] . This paper presents simple, accurate and precise visual titrimetric volumetric method for the determination of Cyproheptadine hydrochloride (CPH) in pharmaceuticals. In this paper we have used Pyridinium fluoro chromate (PFC) as an oxidizing reagent due to its low cost, easy preparation, high solubility and yield, less toxicity and short reaction duration with the drug Cyproheptadine hydrochloride (CPH).
II.
Materials And Methods 
Potassium Iodide( 10%):
10% W/V aqueous solution was prepared in distilled water. The Potassium iodide used for an experiment is of AR grade of RANKEM.
Starch Solution (1%) :
1% of W/V aqueous solution of starch (LOBA Chemie) was prepared in boiling distilled water. The paste formed this way was filtered and kept to cool for some minutes. Always fresh starch solution has been prepared for accurate results.
Preparation of Sample Solution :
Taken 100 mg pure compound of Cyproheptadine hydrochloride (CPH) supplied on request, as gift sample by CIPLA Ltd, Mumbai in 100 ml volumetric flask and dissolved it in 20 ml of methyl alcohol (FISHER).The solution of volumetric flask has been shaken thoroughly for twenty minute so that compound may dissolve properly. After getting homogenous solution the flask was made upto the mark with distilled water.
Preparation of tablet Solution:
Taken 20 Ciplactin-4mg tablets (Manufactured by Cipla Ltd, Sigaddi, Kotdwar, Pauri Garhwal) has been obtained from local commercial source and these tablets were crushed to fine power. The powder equivalent to 100 mg of sample, was taken in 100 ml calibrated flask and dissolved in the same process as described above for the pure solution of CPH.
Method:
Aliquots of drug samples containing 1 to 5 mg were taken in 100 ml stoppered conical flask (Iodine flask) and to this 5 ml of 0.03 N PFC reagent (Prepared in 60% acetic acid) was added to it. Again 10 ml of 5N sulphuric acid was added to same reaction mixture of said flask. There after reaction mixture was shaken thoroughly, in order to mix the contents of flask properly and kept to stand the whole solution of flask for required reaction time at room temperature (25-30 o C) so that reaction between the contents of flask may be completed. After the completion of reaction 5 ml of 10% KI was added to same reaction mixture and whole reaction mixture was shaken properly and again allowed to stand for one minute. The unconsumed PFC was determined by iodometric titration by using starch as an indicator. Similarly blank experiment was also performed using all the regents under identical condition except the drug sample. The amount of PFC consumed for the given drug sample was calculated by the difference in the titre values of
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DOI: 10.9790/5736-1007020104 www.iosrjournals.org 3 |Page sodium thio sulphate solution for blank and actual experiment. The recovery of the drug sample was calculated with the amount of PFC consumed for the sample. Later on for accuracy and precision percentage error, coefficient of variation and standard deviation of each drug sample were calculated. Finally Standard Drug Addition method was also performed to evaluate the authenticity of the method.
Calculation:
The expression used to determine the amount of drug present in the measured aliquot for each experiment is as follows: M X N (B -S) Weight (mg) of sample = n Where, M = Molecular weight of the sample. N = Normality of sodium thiosulphate solution. B = Volume of sodium thiosulphate solution for blank. S = Volume of sodium thiosulphate solution for sample. n = Stoichiometry of the reaction. By using above mentioned process the determination of Cyproheptadine hydrochloride has been achieved for 1-5 mg of pure sample of CPH and in its pharmaceutical preparation (i.e Ciplactin) but for convenience, the results as recorded in Table-1 
III.
Figures & Table   3 .1. Possible course of reaction: The Cyproheptadine hydrochloride (CPH) or dibenzocycloheptene consists of an isosteric vinyl group (cyproheptadine) and the ring nitrogen has been replaced by a sp 2 hybridised carbon atom. The oxidising reagent PFC oxidises the double bond at position 10, 11 of cycloheptene to ketonic group and thus PFC with CPH establishes stoichiometric ratio of 1:1.On the basis of stoichiometric ratio established between PFC and pharmaceutical drug Cyproheptadine hydrochloride (CPH) and after the survey of different literature as mentioned above the proposed reaction may be expressed as: 
IV. Conclusion
The stoichiotric ratio between the PFC reagent and Cyproheptadine hydrochloride (CPH) has been found to be 1:1.This ratio remains constant even under varying reaction conditions i.e. change in concentration of the reagent, reaction time, reaction medium etc.It has been also observed that 0.03N concnetration of PFC and reaction duartion of 10 minute at room temperature is most appropriate condition for the determination of CPH drug.The effect of reaction medium has also been studied and observed that in absence of sulphuric acid
